Agios Pharmaceuticals Inc (AGIO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Agios Pharmaceuticals Inc   (NASDAQ: AGIO)


Agios Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Agios Pharmaceuticals Inc's ROI in the second quarter of 2026?
Agios Pharmaceuticals Inc recorded a cumulative net loss of $-411 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -34.67%.

Within the Healthcare sector 387 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3262 to 3530.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -23.52 % -6.76 % 15.21 % 44.73 % 86.54 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,038 1,145 1,233 1,329 1,418
Return On Investment (TTM) -34.67 % -32.98 % -30.01 % -27.38 % 41.91 %
AGIO's Overall Ranking # 3530 # 3262 # 3136 # 2963 # 14
Seq. Investment Change TTM -7.42 % -6.82 % -6.15 % -5.53 % 12.88 %
Seq. Net Income Change TTM - - - - -2.39 %
Net Income (TTM) in Millions -411 -423 -413 -401 650

AGIO Company Profile >> Back to AGIO Roi Comparisons >> See Annual AGIO Return On Investment



Return On Investment AGIO's Ranking
Within: No.
Industry # 151
Sector # 388
Overall # 3530

Return On Investment Statistics
High Average Low
129.54 %
-11.94 %
-57.96 %
(Mar 31 2021)   (Dec 31 2019)







Financial Statements
Agios Pharmaceuticals Inc's II. Quarter Investments $ 1,038 Millions AGIO's Balance sheet
Agios Pharmaceuticals Inc's II. Quarter Income $ -101 Millions Quarterly AGIO's Income Statement
AGIO's Income by Division See AGIO's Income by Division


AGIO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,215 1,582 869 1,176 1,378
Y / Y Investment Growth -23.2 % 82.02 % -26.1 % -14.65 % 81.65 %
Net Income in Millions -413 674 -352 -232 1,605
Y / Y Net Income Growth - - - - -
Annual Return On Investment -33.97 % 42.59 % -40.51 % -19.71 % 116.46 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AGIO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AGIO's Competitors
Subscribers only: Roi for Agios Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for AGIO's Customers

Other Ratios
AGIO's Roa AGIO's Inventory Turnover Ratio AGIO's Growth Rates AGIO's Dividend Statistics
AGIO's Profitability Ratios AGIO's Asset Turnover Ratio AGIO's Dividend Growth
AGIO's Roe AGIO's Valuation Ratios AGIO's Financial Strength Ratios AGIO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-13T23:38:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.